Skip to main content

Month: February 2026

Barrick Reports Full Year and Fourth Quarter 2025 Results

Record shareholder returns and another record quarterly financial performance mark successful delivery of 2025 operating planQ4 gold production 5% higher than Q3 at 871,000 ounces1, 2025 gold and copper production in line with guidance Record quarterly cash flow with operating cash flow of $2.73 billion and free cash flow2 of $1.62 billion—up 13% and 9%, respectively, over Q3 Highest ever quarterly net earnings per share of $1.43 and adjusted net earnings per share2 of $1.04—up 88% and 79%, respectively, on Q3 New dividend policy targets total payout of 50% of attributable free cash flow, including 40% increase in quarterly base dividend to $0.175 per share, plus performance year end top-up $0.42 per share quarterly dividend declared—a 140% increase over the third quarter Repurchased $1.50 billion of shares in 2025, representing about...

Continue reading

Prestige Consumer Healthcare Inc. Reports Third Quarter and Year-to-Date Fiscal 2026 Results

Revenue of $283.4 million in Q3, ahead of outlook Diluted EPS of $0.97 in Q3 and Adjusted Diluted EPS of $1.14, versus prior year Q3 Diluted EPS of $1.22 Repurchased approximately 0.8 million shares opportunistically in Q3 Successfully closed acquisition of eye care supplier Pillar5 Pharma, Inc. in December, as expected Narrowing Outlook Range of Fiscal 2026 Revenue and Adjusted Diluted EPSTARRYTOWN, N.Y., Feb. 05, 2026 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter and nine months ended December 31, 2025. “We exceeded our third quarter revenue outlook and delivered solid profitability in the quarter, which reflected the benefits of our diverse business model and strong financial profile. We are pleased with these results, especially when navigating the...

Continue reading

Barrick Declares Increased Dividend and Announces New Dividend Policy

All amounts expressed in U.S. dollars TORONTO, Feb. 05, 2026 (GLOBE NEWSWIRE) — Barrick Mining Corporation (NYSE:B)(TSX:ABX) (“Barrick” or the “Company”) today announced the declaration of a $0.42 per share dividend in respect of performance for the fourth quarter of 2025, representing an increase of 140% over the third quarter, and announced a new dividend policy. The Q4 2025 dividend will be paid on March 16, 2026 to shareholders of record at the close of business on February 27, 2026. In addition to the dividend, Barrick repurchased approximately 12.11 million shares during Q4 under the share buyback program that was announced in February 2025. During the year, Barrick repurchased approximately 51.90 million shares under the 2025 program, or approximately 3.0% of Barrick’s issued and outstanding shares at the time this year’s...

Continue reading

GXO Accelerates Aerospace & Defence Expansion with BAE Systems Renewal in UK

GXO announced a contract renewal and expansion in the UK with BAE SystemsThe agreement will usher the partnership into its third decade and support BAE Systems development of world-class Type 26 frigates.BAE Systems and GXO to extend relationship into its third decade LONDON, U.K., Feb. 05, 2026 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, today announced a contract renewal and expansion in the UK with BAE Systems, a leading provider of advanced, technology-led defence, aerospace and security solutions. The six-year agreement will usher the partnership into its third decade and further support BAE Systems in the development of world-class Type 26 frigates. “For more than two decades, we have partnered with BAE Systems to deliver innovative, tech-enabled...

Continue reading

Precore Gold Completes 100% Acquisition of the Lac Big-Rush Gold Property in the Prolific Chibougamau Mining Camp of Quebec

VANCOUVER, British Columbia, Feb. 05, 2026 (GLOBE NEWSWIRE) — Precore Gold Corp. (CSE: PRCG) (the “Company” or “Precore Gold”) is pleased to announce that further to it’s Definitive Option Agreement (the “Agreement”) announced February 04, 2025 to acquire a 100% undivided interest in the Lac Big-Rush Gold Property (the “Property”) from a single private owner (The “Vendor”), it has accelerated and modified it’s Agreement to immediately own 100% of the Property. Initially the Company entered into a Definitive Option Agreement to acquire 100% of the property over a 3-year period. However, given the discovery potential of the property in this prolific mining camp, the Company has accelerated the original terms to complete 100% ownership. This development is especially important as it comes on the heals of a noteworthy sector M&A...

Continue reading

Danske Mortgage Bank Plc: Annual Report 2025 and Auditor’s report 2025

Attached Danske Mortgage Bank Plc’s Annual Report 2025 and Auditor’s Report 2025. The Annual Report is reported in pdf and also in accordance with the European Single Electronic Format (ESEF) reporting requirements in Extensible Hypertext Markup Language (XHTML).  Annual Report and Auditor’s Report can be found from the company’s webpages https://danskebank.com/investor-relations/debt/danske-mortgage-bank Danske Mortgage Bank Plc Contact: Janne Lassila, CEO, Danske Mortgage Bank Plc, tel. +358 (0) 40 515 8911AttachmentsDanske Mortgage Bank Plc Annual Report 20257437003G88EHT2TMK409-2025-12-31-enDanske Mortgage Bank Plc – Auditors Report 2025

Continue reading

EXACT Therapeutics: Exercise of Warrants by GE Medical Holding AB

GE Medical Holding AB exercises all its Warrants in EXACT Therapeutics resulting in gross proceeds of NOK 33 million. Reference is made to the stock exchange announcement published on 27 January 2026 by EXACT Therapeutics, announcing that:The Trial Monitoring Committee has issued a positive conclusion for the pre-planned safety read-out and the phase 2 trial proceeds as planned. This triggers the option to exercise Warrants. Early, encouraging tumour shrinkage, and significant decrease in tumour biomarker CA 19-9 (>85% decrease, unaudited data).OSLO, Norway, Feb. 05, 2026 (GLOBE NEWSWIRE) — Reference is made to the stock exchange announcement by EXACT Therapeutics AS (the “Company”, Euronext Growth ticker: EXTX), a clinical-stage precision medicine company, on 27 January 2026, referring to the Company’s private...

Continue reading

Jyske Realkredit A/S publishes Supplement no 1 to Base prospectus dated 27 June 2025

To Nasdaq Copenhagen A/S                        05 February 2026                                        Announcement no. 12/2026 Jyske Realkredit A/S publishes Supplement no 1 to Base prospectus dated 27 June 2025 Jyske Realkredit hereby publish Supplement no. 1 to Base prospectus dated 27 June 2025 for covered bonds, mortgage bonds and bonds issued pursuant to Section 15 of the Danish Mortage-Credit Loans and Mortgage-Credit Bonds etc. Act. Jyske Realkredit’s Base Prospectus dated 27 June 2025 and Supplements are available for download in Danish and English on Jyske Realkredit’s website www.jyskerealkredit.dk. In the event of discrepancies between the original Danish text and the English translation, the Danish text shall prevail. Jyske Realkredit’s Supplement no 1 is also enclosed this announcement. For more information, please contact:Head...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.